Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosis

Area of Science:

• Genetics
• Molecular Biology
• Medical Research

Background:

• Primary hypertrophic osteoarthropathy (PHO) is a rare genetic disorder.
• It exhibits reduced penetrance in females.
• Genetic mutations in HPGD and SLCO2A1, involved in prostaglandin E2 metabolism, are associated with PHO.

Purpose of the Study:

• To investigate the genetic basis of PHO in five patients from four families.
• To identify specific mutations responsible for the disorder.
• To explore the role of SLCO2A1 in PHO pathogenesis.

Main Methods:

• Whole-exome sequencing was used to identify mutations in two brothers.
• Sanger sequencing was employed for mutation analysis in three other families.
• Genetic analysis focused on HPGD and SLCO2A1 genes.

Main Results:

• No mutations were found in the HPGD gene.
• Homozygous or compound heterozygous mutations in SLCO2A1 were identified as the cause of PHO.
• A female patient with SLCO2A1 mutations did not exhibit typical PHO symptoms, suggesting reduced penetrance.

Conclusions:

• Mutations in SLCO2A1 are confirmed as the pathogenic cause of PHO.
• The findings highlight the role of SLCO2A1 in prostaglandin E2 metabolism and PHO development.
• Reduced penetrance in females warrants further investigation into the influence of sex hormones on PHO pathogenesis.